Literature DB >> 8916770

Hormone replacement therapy for all? Long-term randomised controlled trial is needed.

R Lyons.   

Abstract

Mesh:

Year:  1996        PMID: 8916770      PMCID: PMC2352489          DOI: 10.1136/bmj.313.7066.1206

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  Prevalence and determinants of estrogen replacement therapy in elderly women.

Authors:  J A Cauley; S R Cummings; D M Black; S R Mascioli; D G Seeley
Journal:  Am J Obstet Gynecol       Date:  1990-11       Impact factor: 8.661

2.  Postmenopausal estrogen and prevention bias.

Authors:  E Barrett-Connor
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

3.  Women need to be fully informed about risks of hormone replacement therapy.

Authors:  E H Price; H K Little
Journal:  BMJ       Date:  1996-05-18

4.  Use of hormone replacement therapy. Evidence on risk of breast cancer associated with hormone replacement therapy is still inconclusive.

Authors:  K Mckinney
Journal:  BMJ       Date:  1996-09-14

5.  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.

Authors:  G A Colditz; S E Hankinson; D J Hunter; W C Willett; J E Manson; M J Stampfer; C Hennekens; B Rosner; F E Speizer
Journal:  N Engl J Med       Date:  1995-06-15       Impact factor: 91.245

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.